Gustavo C. Girotto
Sao Jose Do Rio Preto, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Adverse event profile following maintenance olaparib in patients with BRCA-mutated platinum-sensitive relapsed serous ovarian cancer in the phase III SOLO2 trial.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: October 16, 2025
Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 06, 2022
Abiraterone and Olaparib for Metastatic Castration-Resistant Prostate Cancer.
Journal: NEJM evidence
Published: September 01, 2022
Impact of Pembrolizumab Versus Chemotherapy as Second-Line Therapy for Advanced Esophageal Cancer on Health-Related Quality of Life in KEYNOTE-181.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 03, 2021
Sotorasib for previously treated colorectal cancers with KRASG12C mutation (CodeBreaK100): a prespecified analysis of a single-arm, phase 2 trial.
Journal: The Lancet. Oncology
Published: September 10, 2021
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 07, 2020
Tumor Response and Symptom Palliation from RAINBOW, a Phase III Trial of Ramucirumab Plus Paclitaxel in Previously Treated Advanced Gastric Cancer.
Journal: The oncologist
Published: April 28, 2020
SELECT-2: a phase II, double-blind, randomized, placebo-controlled study to assess the efficacy of selumetinib plus docetaxel as a second-line treatment of patients with advanced or metastatic non-small-cell lung cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 19, 2017
A randomised phase II study of chemoradiotherapy with or without nimotuzumab in locally advanced oesophageal cancer: NICE trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 19, 2017
Guidelines for the management of neuroendocrine tumours by the Brazilian gastrointestinal tumour group.
Journal: Ecancermedicalscience
Published: November 09, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026